UK markets closed

Cadrenal Therapeutics, Inc. (CVKD)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4801+0.0382 (+8.64%)
At close: 04:00PM EDT
0.4500 -0.03 (-6.27%)
After hours: 07:48PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.4419
Open0.4600
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.4400 - 0.5100
52-week range0.3600 - 3.1400
Volume180,109
Avg. volume220,852
Market cap7.686M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

    MIAMI, June 12, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 72nd Emerging Growth Conference on June 12 & 13, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani

  • PR Newswire

    Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024

    Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, new-generation Vitamin K Antagonist (VKA) oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions, today announced that the Company will be participating in the Emerging Growth Conference on June 12, 2024.

  • GlobeNewswire

    Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

    MIAMI, June 11, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 72nd Emerging Growth Conference on June 12 & 13, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani